SCHEMBL31452066

SCHEMBL31452066

O=C(Nc1ccccc1)c1ncn2c(=O)n(CCOC(F)(F)F)nnc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.43
TP53 P04637 2/20 0.41
POLB P06746 1/20 0.38
MEN1 O00255 4/20 0.38
KMT2A Q03164 4/20 0.38
CA12 O43570 3/20 0.38
CA1 P00915 3/20 0.38
CA2 P00918 3/20 0.38
CA9 Q16790 3/20 0.38
HSD17B10 Q99714 2/20 0.38
AKR1C3 P42330 1/20 0.36
AKR1C2 P52895 1/20 0.36
PABPC1 P11940 1/20 0.36
HPGD P15428 1/20 0.36
HTT P42858 1/20 0.35
BCAT2 O15382 1/20 0.35
KDM4E B2RXH2 1/20 0.35
ALPG P10696 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31452059 0.89 GRM5 (0.38) ALDH1A1TP53MEN1KMT2ACA12
SCHEMBL31451991 0.89 CA12 (0.38) ALDH1A1TP53MEN1KMT2ACA12
SCHEMBL31451960 0.88 HDAC1 (0.38) TP53MEN1KMT2ACA12CA1
SCHEMBL31452075 0.85 CA12 (0.39) ALDH1A1POLBMEN1KMT2ACA12
SCHEMBL31451983 0.84 KMT2A (0.45) MEN1KMT2ACA12CA1CA2
SCHEMBL31452053 0.84 CA12 (0.43) MEN1KMT2ACA12CA1CA2
SCHEMBL31452006 0.83 KMT2A (0.37) ALDH1A1TP53MEN1KMT2ACA12
SCHEMBL31452096 0.81 MEN1 (0.44) MEN1KMT2ACA12CA1CA2
SCHEMBL31452072 0.81 MEN1 (0.41) MEN1KMT2ACA12CA1CA2
SCHEMBL31452056 0.81 MEN1 (0.56) MEN1KMT2ACA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250066371-A1 FLUOROALKOXYALKYLENE-DIHYDROIMIDAZO[5,1-D]TETRAZINONE COMPOUNDS AND RELATED COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS MODIFI BIOSCIENCES, INC. 2025-02-27 US disclosed
WO-2025034537-A1 FLUOROALKOXYALKYLENE-DIHYDROIMIDAZO[5,1-D]TETRAZINONE COMPOUNDS AND RELATED COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS MODIFI BIOSCIENCES, INC. (US) 2025-02-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250066371-A1 FLUOROALKOXYALKYLENE-DIHYDROIMIDAZO[5,1-D]TETRAZINONE COMPOUNDS AND RELATED COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS PKD1, APC, VHL ALDH1A1 50/4885TP53 57/4885POLB 2091/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.